+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Distribution of ethanolamine oleate after injection in esophageal varices



Distribution of ethanolamine oleate after injection in esophageal varices



Nihon Geka Gakkai Zasshi 85(12): 1523-1527



The purpose of this study is to know the systemic distribution of sclerosant injected into esophageal varices. Sclerotherapy for esophageal varices was performed for 14 times in 11 patients. The patients were divided into two groups according to the content of sclerosant. Seven patients received a total of 9 intravariceal injections (IVI) with 7 to 30ml of 5% ethanolamine oleate (EO) which contained meglumine diatrizoate (Angiographin) and four patients received a total of 5 IVI with 10 to 20ml of 4.5% EO which contained a 10% volume of 99mTcO-4 solution (EO-99mTc). Distribution of injected materials was observed by X-ray fluoroscopy in the former group and by a scintillation camera in the latter. In both methods most of the sclerosant disappeared from the injected site within five minutes leaving a trace in the varices. Then, the sclerosant was disseminated throughout the body via portal vein. When more than 20ml of sclerosant was injected, some flowed into the azygos vin through the periesophageal vin. After IVI the varices showed atrophic changes, though the sclerosant did not stay in the varices.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042841011

Download citation: RISBibTeXText

PMID: 6527680


Related references

Injection sclerotherapy of esophageal varices using ethanolamine oleate. American Journal of Surgery 143(4): 426-431, 1982

Esophageal stricture due to endoscopic injection sclerotherapy for esophageal varices using 5 percent ethanolamine oleate. Gastroenterological Endoscopy 31(4): 831-836, 1989

Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Hepato-Gastroenterology 39(6): 546-548, 1992

Studies on various esophageal lesions due to paravariceal injections of 5 percent ethanolamine oleate during endoscopic injection sclerotherapy of esophageal varices. Gastroenterological Endoscopy 28(10): 2257-2267, 1986

Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices. Hepato-Gastroenterology 37(6): 565-568, 1990

Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices. Endoscopy 21(1): 50, 1989

Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices. Archives of Surgery 120(7): 833-836, 1985

Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7(5): 810-815, 1987

Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Hepato-Gastroenterology 34(1): 19-23, 1987

A comparison between endoscopic injection of bleeding esophageal varices using ethanolamine oleate and fibrin glue sealant in patients with bilharzial liver fibrosis. Endoscopy 31(5): 405, 1999

Ethanolamine oleate for esophageal varices. Medical Letter on Drugs and Therapeutics 31(804): 99-100, 1989

Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices. Nihon Rinsho. Japanese Journal of Clinical Medicine 48(4): 713-717, 1990

Is ethanolamine oleate an ideal sclerosing agent for the treatment of esophageal varices. U S Pharmacist 15(6): 60-61, 1990

Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate. American Journal of Gastroenterology 86(9): 1182-1184, 1991

Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices. Gastrointestinal Endoscopy 51(5): 573-576, 2000